Atrinsic Inc. (NASDAQ:PTIX – Get Free Report) shares shot up 15.8% during trading on Thursday . The company traded as high as $0.22 and last traded at $0.22. Approximately 34,113 shares were traded during mid-day trading, an increase of 5% from the average session volume of 32,536 shares. The stock had previously closed at $0.19.
Atrinsic Price Performance
The company has a market cap of $398,200.00, a price-to-earnings ratio of -0.03 and a beta of 1.01. The firm has a 50 day simple moving average of $0.50 and a 200-day simple moving average of $0.58.
Atrinsic Company Profile
Protagenic Therapeutics, Inc, a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. Its lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc is headquartered in New York, New York.
Featured Articles
- Five stocks we like better than Atrinsic
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Atrinsic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrinsic and related companies with MarketBeat.com's FREE daily email newsletter.
